Valerie M. Jansen, M.D., Ph.D., was previously the Chief Medical Officer of Elevation Oncology, Inc. (NASDAQ: ELEV) and has served as the Vice President of Clinical Development. Previously, she served as Executive Medical Director of Mersana Therapeutics (NASDAQ: MRSN) and Senior Medical Advisor at Eli Lilly (NASDAQ: LLY). Prior to Eli Lilly, Dr. Jansen was employed at the Vanderbilt University Medical Center serving, most recently, as Adjunct Instructor in Medicine. Dr. Jansen received a B.A. in Chemistry from Maryville College, a Ph.D. in Molecular Sciences from the University of Tennessee Health Science Center and an M.D. from the University of Chicago Pritzker School of Medicine. She is board certified in Internal Medicine and Medical Oncology.
